SOURCE: BIOLASE Technology, Inc.

BIOLASE Technology, Inc.

August 27, 2010 06:00 ET

BIOLASE Names Federico Pignatelli Executive Chairman

IRVINE, CA--(Marketwire - August 27, 2010) -  BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, is pleased to announce the appointment of Federico Pignatelli as Executive Chairman effective August 24, 2010. Mr. Pignatelli takes over from David M. Mulder, who resigned as Chairman, CEO, and President to pursue other opportunities. Mr. Pignatelli has previously served, over the past 16 years, as Chairman of the Board, Interim CEO, and President.

Mr. Pignatelli stated, "We now have an entirely new board and I am very pleased to return to the Chairman role after almost 5 years. Historically, during my tenure as Chairman the company enjoyed its greatest growth years. I had personally requested that David take the reigns as CEO almost a year and a half-ago, during a very difficult economic and valuation environment, and we appreciate his untiring efforts to guide the company through those challenges and to help us lay a foundation for the future. We wish him well." 

Mr. Mulder commented, "It is a natural time to transition the Chairmanship role at BIOLASE. We have spent the past two years keeping the Company viable and weathering a very rough economy, while laying the groundwork for a completely new commercial strategy. Now it is time to execute that strategy with boldness and a single point of leadership to ensure its success. I would encourage everyone to follow Federico's leadership as they have followed my own. I wish the company well and appreciate having had the opportunity to serve you."

About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on laser and Waterlase dentistry, find BIOLASE at, Twitter at, Facebook at, and YouTube at

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

Contact Information

  • For further information, please contact:
    Jill Bertotti
    Allen & Caron